FNP 1 EXAM STUDY GUIDE FOR NURS 5432 QUESTIONS AND CORRECT ANSWERS

FNP 1 EXAM STUDY GUIDE FOR
NURS 5432 QUESTIONS AND
CORRECT ANSWERS
VaccinationsA2-A2Ans--ImmunizationsA2shouldA2notA2beA2delayedA2forA2minorA2illnesses.

RotavirusA2VaccinesA2-A2Ans--
TwoA2types:A2RotarixA2andA2RotateqA2withA2specificA2dosing.

ImmunodeficientA2ChildrenA2-A2Ans--Live-
virusA2vaccinesA2areA2contraindicatedA2forA2theseA2patients.

KnownA2AllergiesA2-A2Ans--ChildrenA2withA2allergiesA2mayA2needA2vaccineA2adjustments.

RVA2VaccineA2-A2Ans--RareA2intussusceptionA2risk;A2avoidA2inA2certainA2conditions.

DevelopmentalA2MilestonesA2-A2Ans--
KeyA2skillsA2childrenA2shouldA2achieveA2byA2specificA2ages.

TannerA2StagesA2-A2Ans--SystemA2forA2assessingA2sexualA2maturationA2stages.

StageA21A2TannerA2-A2Ans--Pre-pubertalA2stageA2withA2noA2pubicA2hair.

StageA22A2TannerA2-A2Ans--SoftA2pubicA2hair;A2breastA2budsA2inA2females.

StageA23A2TannerA2-A2Ans--CoarserA2pubicA2hair;A2penisA2enlargementA2inA2males.

StageA24A2TannerA2-A2Ans--PubicA2hairA2coversA2area;A2breastA2moundA2development.

StageA25A2TannerA2-A2Ans--AdultA2stage;A2fullA2developmentA2ofA2genitalia.

AutismA2-A2Ans--SymptomsA2typicallyA2presentA2beforeA2ageA23.

AUBA2ClassificationA2-A2Ans--DescribesA2abnormalA2uterineA2bleedingA2patterns.

PAPA2ScreeningA2GuidelinesA2-A2Ans--
RecommendationsA2forA2cervicalA2cancerA2screeningA2ages.

ChronicA2DiseasesA2-A2Ans--NotA2outrightA2contraindicationsA2forA2vaccinations.

PrematureA2InfantsA2-A2Ans--ImmunizationA2scheduleA2basedA2onA2chronologicalA2age.

,LiveA2VirusA2VaccinesA2-A2Ans--ContraindicatedA2inA2immunocompromisedA2children.

NeomycinA2AllergyA2-A2Ans--AvoidA2MMR,A2IPV,A2VARA2inA2allergicA2children.

EggA2AllergyA2-A2Ans--InfluenzaA2vaccineA2canA2beA2givenA2withA2precautions.

DevelopmentalA2ControlA2-A2Ans--HeadA2controlA2byA23A2months;A2sittingA2byA26A2months.

PincerA2GraspA2-A2Ans--DevelopsA2betweenA28-10A2monthsA2ofA2age.

WalkingA2MilestoneA2-A2Ans--TypicallyA2achievedA2byA21A2yearA2ofA2age.

BabblingA2-A2Ans--PeaksA2atA212A2months;A2beginsA2wordA2usage.

ExpressiveA2VocabularyA2-A2Ans--ExpandsA2significantlyA2fromA212A2toA224A2months.

SpeechA2ComprehensionA2-A2Ans--100%A2comprehensionA2byA2kindergartenA2age.

HospitalizedA2ChildrenA2-A2Ans--VaccinationA2deferredA2untilA2post-discharge.

SevereA2CombinedA2ImmunodeficiencyA2-A2Ans--
ContraindicatesA2RVA2vaccinesA2inA2infants.

GastroenteritisA2-A2Ans--VaccinationA2deferredA2inA2acuteA2moderateA2orA2severeA2cases.

PAPA2testA2-A2Ans--ScreeningA2forA2cervicalA2cancer;A2firstA2atA2ageA221.

HPVA2testingA2-A2Ans--DeterminesA2subtypeA2ofA2humanA2papillomavirus.

ColposcopyA2-A2Ans--ExaminationA2ofA2cervixA2afterA2abnormalA2PAPA2results.

VaginalA2candidiasisA2treatmentA2-A2Ans--
TopicalA2orA2oralA2antifungalsA2likeA2Clotrimazole.

Bartholin'sA2glandA2cystA2managementA2-A2Ans--
IncisionA2andA2drainage;A2wordA2catheterA2forA24-6A2weeks.

PALM-COEINA2-A2Ans--AcronymA2forA2causesA2ofA2abnormalA2uterineA2bleeding.

PolypA2-A2Ans--BenignA2growthA2inA2theA2uterineA2lining.

AdenomyosisA2-A2Ans--EndometrialA2tissueA2growsA2intoA2uterineA2muscle.

LeiomyomaA2-A2Ans--BenignA2smoothA2muscleA2tumorsA2inA2premenopausalA2women.

CoagulopathyA2-A2Ans--BloodA2disorderA2causingA2abnormalA2bleeding.

, OvulatoryA2dysfunctionA2-A2Ans--IrregularA2ovulationA2leadingA2toA2menstrualA2issues.

EndometrialA2-A2Ans--ReferringA2toA2theA2uterineA2lining.

IatrogenicA2-A2Ans--CausedA2byA2medicalA2treatmentA2orA2device.

PCOSA2-A2Ans--PolycysticA2ovarianA2syndrome;A2hormonalA2imbalance.

AndrogenA2excessA2-A2Ans--HighA2levelsA2ofA2maleA2hormonesA2inA2females.

InsulinA2resistanceA2-A2Ans--Body'sA2cellsA2doA2notA2respondA2toA2insulin.

DHEA-SA2-A2Ans--HormoneA2indicatingA2adrenalA2function;A2elevatedA2inA2PCOS.

TSHA2-A2Ans--Thyroid-stimulatingA2hormone;A2assessesA2thyroidA2function.

A1c/OGTTA2-A2Ans--TestsA2forA2diabetes;A2OGTTA2preferredA2forA2obesity.

MetabolicA2syndromeA2-A2Ans--ClusterA2ofA2conditionsA2increasingA2heartA2diseaseA2risk.

WeightA2reductionA2-A2Ans--10%A2lossA2improvesA2insulinA2andA2menstrualA2function.

CombinedA2hormonalA2contraceptivesA2-A2Ans--First-
lineA2forA2managingA2PCOSA2symptoms.

LetrozoleA2-A2Ans--First-lineA2medicationA2forA2ovarianA2stimulation.

VulvovaginalA2candidiasisA2-A2Ans--FungalA2infection;A2mayA2haveA2satelliteA2lesions.

LabialA2adhesionsA2-A2Ans--CommonA2conditionA2inA220%A2ofA2females.

DiflucanA2-A2Ans--OralA2antifungalA2forA2treatingA2candidiasis.

MenstrualA2irregularityA2-A2Ans--VariedA2menstrualA2cycles;A2includesA2amenorrhea.

HirsutismA2-A2Ans--ExcessiveA2hairA2growthA2inA2females;A2maleA2patterns.

OvarianA2morphologyA2-A2Ans--PresenceA2ofA2cystsA2inA2ovaries;A2PCOSA2indicator.

SatelliteA2lesionsA2-A2Ans--SecondaryA2skinA2lesionsA2oftenA2associatedA2withA2infections.

POA2ABXA2-A2Ans--OralA2antibioticsA2thatA2mayA2disruptA2normalA2flora.

TerazoleA2-A2Ans--TopicalA2treatmentA2effectiveA2forA2allA2yeastA2types.